147 related articles for article (PubMed ID: 28687725)
1. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia.
Zhao FC; Wu Y; Song XJ
Med Sci Monit; 2017 Jul; 23():3311-3317. PubMed ID: 28687725
[TBL] [Abstract][Full Text] [Related]
2. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's.
Sun ZQ; Tu LX; Zhuo FJ; Liu SX
Bioorg Med Chem Lett; 2016 Feb; 26(3):747-750. PubMed ID: 26783181
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
4. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
[TBL] [Abstract][Full Text] [Related]
6. Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
Bowroju SK; Penthala NR; Lakkaniga NR; Balasubramaniam M; Ayyadevara S; Shmookler Reis RJ; Crooks PA
Bioorg Med Chem; 2021 Sep; 45():116311. PubMed ID: 34304133
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
8. Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease.
Bajad NG; Singh RB; T A G; Gutti G; Kumar A; Krishnamurthy S; Singh SK
Bioorg Chem; 2024 Feb; 143():107082. PubMed ID: 38199142
[TBL] [Abstract][Full Text] [Related]
9. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
13. Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly.
Thamban Chandrika N; Fosso MY; Tsodikov OV; LeVine Iii H; Garneau-Tsodikova S
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878304
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
Liu H; Fan H; Gao X; Huang X; Liu X; Liu L; Zhou C; Tang J; Wang Q; Liu W
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):580-9. PubMed ID: 26186269
[TBL] [Abstract][Full Text] [Related]
15. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.
Ghobadian R; Mahdavi M; Nadri H; Moradi A; Edraki N; Akbarzadeh T; Sharifzadeh M; Bukhari SNA; Amini M
Eur J Med Chem; 2018 Jul; 155():49-60. PubMed ID: 29857276
[TBL] [Abstract][Full Text] [Related]
16. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
17. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group.
Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600
[TBL] [Abstract][Full Text] [Related]
18. Analogues of 2'-hydroxychalcone with modified C4-substituents as the inhibitors against human acetylcholinesterase.
Sukumaran SD; Nasir SB; Tee JT; Buckle MJC; Othman R; Rahman NA; Lee VS; Bukhari SNA; Chee CF
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):130-137. PubMed ID: 33243025
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening.
Liu G; Jiao Y; Lin Y; Hao H; Dou Y; Yang J; Jiang CS; Chang P
Chem Pharm Bull (Tokyo); 2020 Feb; 68(2):161-166. PubMed ID: 31813907
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
Liu HR; Liu XJ; Fan HQ; Tang JJ; Gao XH; Liu WK
Bioorg Med Chem; 2014 Nov; 22(21):6124-33. PubMed ID: 25260958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
